임신 중 lithium carbonate을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

lithium carbonate은 임신 중 안전한가요?

ECHA’s Risk Assessment Committee adopted an opinion classifying lithium carbonate (CAS 554-13-2) as Reproductive Toxicity Category 1A (H360; effect on fertility/foetus) with effects via lactation (H362), which is harmonised-level evidence of reproductive/developmental hazard; clinical and animal literature also document placental transfer and neonatal/fetal effects for systemic (medicinal) lithium exposure. For topical cosmetic use systemic exposure is expected to be negligible (see ECHA registration dossier dermal absorption statement). (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed reviews/studies).

lithium carbonate은 모유 수유 중 안전한가요?

ECHA’s adopted opinion includes H362 (dangerous for or via breast‑feeding), and clinical data on medicinal lithium show lithium is excreted in human milk and can produce neonatal toxicity—supporting a high hazard (h=3) and demonstrated mechanism (m=2). For topical cosmetic applications, dermal absorption is considered very poor so direct exposure via cosmetic use is expected to be negligible, though systemic exposure from medicinal use is well documented. (Sources: ECHA RAC CLH opinion; ECHA registration dossier; product/labeling and clinical literature on lithium in breast milk).

lithium carbonate은 아기 피부에 안전한가요?

Hazard and mechanism are driven by harmonised CLH (Repr.1A H360FD) and clinical/animal evidence of placental transfer and milk excretion—these apply to infants (h=3, m=2). Exposure (e) for topical cosmetic use is judged low/negligible in adults (ECHA: dermal absorption very poor), but infant skin has higher uptake potential so exposure is increased by +1 to e=1 as a precaution for 0–3‑year skin when the ingredient is present in topical products. There is no evidence that cosmetic-grade topical use produces systemic infant exposure, but the harmonised classification leads to conservative scoring for infant contexts. (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed clinical/animal studies).

VeriMom은 lithium carbonate을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 lithium carbonate을 27/100 (높은 위험)로 평가합니다.

임신 중 lithium carbonate 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.